R&D

Gene Therapy of ANLBIO

Gene therapy for neurodegenerative diseases targeting microRNA and others

  • DNA Sequence

    01
  • AAV vector as a delivering vehicle

    02
  • Single injection

    03
  • Long-lasting effect

    04
AAV Delivery Platform of ANLBIO

Safe arrival of transgenes into nuclei is all about gene therapy drugs
ANLBIO answers tocommercial challenges of gene therapy modalities with an innovative delivery platform of viral vectors including AAV

  • Enhanced Random Mutagenesis System (ERMS)

    01
  • Mutation of capsid protein at multiple position

    02
  • Revamped screening by barcode & deep sequencing

    03
  • Capsid protein library

    04